Annual Report for 2019 by the Japanese Association for Coronary Artery Surgery

Aya Saito1,2, Noboru Motomura1,2, Hiraku Kumamaru3

  • 1Committee for Scientific Affairs, Japanese Association for Coronary Artery Surgery, Tokyo, Japan.

Insights

Annual reporting on coronary artery bypass grafting (CABG) in Japan shows stable surgical strategies and clinical outcomes. This analysis of 2019 data from the Japanese Cardiovascular Surgery Database (JCVSD) highlights trends in surgical practice for ischemic heart disease.

Area of Science:

  • Cardiovascular Surgery
  • Public Health Surveillance
  • Quality Improvement in Healthcare

Background:

  • Continuous annual reporting is crucial for monitoring and enhancing coronary artery bypass grafting (CABG) surgical practices.
  • Understanding national trends in coronary artery disease extent and patient characteristics is vital for quality control.

Purpose of the Study:

  • To present Japanese nationwide features and trends in coronary artery disease and CABG procedures in 2019.
  • To analyze clinical results related to ischemic heart disease treated with CABG.

Main Methods:

  • Utilized the Japanese Cardiovascular Surgery Database (JCVSD), a nationwide surgical case registry.
  • Collected data for 2019 CABG cases via questionnaires administered by the Japanese Association for Coronary Artery Surgery (JACAS).
  • Analyzed graft selection trends based on the number of diseased vessels and clinical outcomes for acute myocardial infarction and ischemic mitral regurgitation.

Main Results:

  • The study presents the second summary of JACAS annual report results based on 2019 JCVSD data.
  • Trends in graft selection and clinical outcomes for CABG procedures were observed to be relatively stable.
  • Descriptive clinical results for patients undergoing surgery for acute myocardial infarction or ischemic mitral regurgitation were analyzed.

Conclusions:

  • Clinical outcomes and surgical strategy trends in Japanese CABG practices remained relatively stable in 2019.
  • This report provides valuable insights into national surgical practices and outcomes.
  • Continued data collection through similar systems is expected to further inform clinical practice and research.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
28
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
14
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11